Repositori URV

Identifier: imarina:9173237

Handle: https://hdl.handle.net/20.500.11797/imarina9173237

Authors:
Atzeni, AlessandroGalie, SerenaMuralidharan, JananeeBabio, NancyTinahones, Francisco JoseVioque, JesusCorella, DoloresCastaner, OlgaVidal, JosepMoreno-Indias, IsabelTorres-Collado, LauraFernandez-Carrion, RebecaFito, MontserratOlbeyra, RominaMartinez-Gonzalez, Miguel AngelBullo, MonicaSalas-Salvado, Jordi

Abstract:
Gut microbiota is essential for the development of obesity and related comorbidities. However, studies describing the association between specific bacteria and obesity or weight loss reported discordant results. The present observational study, conducted within the frame of the PREDIMED-Plus clinical trial, aims to assess the association between fecal microbiota, body composition and weight loss, in response to a 12-month lifestyle intervention in a subsample of 372 individuals (age 55-75) with overweight/obesity and metabolic syndrome. Participants were stratified by tertiles of baseline body mass index (BMI) and changes in body weight after 12-month intervention. General assessments, anthropometry and biochemical measurements, and stool samples were collected. 16S amplicon sequencing was performed on bacterial DNA extracted from stool samples and microbiota analyzed. Differential abundance analysis showed an enrichment of Prevotella 9, Lachnospiraceae UCG-001 and Bacteroides, associated with a higher weight loss after 12-month of follow-up, whereas in the cross-sectional analysis, Prevotella 2 and Bacteroides were enriched in the lowest tertile of baseline BMI. Our findings suggest that fecal microbiota plays an important role in the control of body weight, supporting specific genera as potential target in personalized nutrition for obesity management. A more in-depth taxonomic identification method and the need of metabolic information encourages to further investigation.